The longitudinal course of gross motor activity in schizophrenia - within and between episodes

Frontiers in Psychiatry

Volumn 6, Issue FEB, 2015, Pages

  Walther, Sebastian ^a   Stegmayer, Katharina ^a   Horn, Helge ^a   Rampa, Luca ^a   Razavi, Nadja ^a   Müller, Thomas J ^a   Strik, Werner ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Actigraphy; Avolition; Negative symptoms; PANSS; Psychosis

Indexed keywords

ACTIMETRY; ADULT; ARTICLE; BEHAVIOR CHANGE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GROSS MOTOR ACTIVITY; HUMAN; MALE; MOTOR ACTIVITY; NEGATIVE SYNDROME; NON INVASIVE MEASUREMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PREDICTION; PSYCHOLOGICAL RATING SCALE; PSYCHOMOTOR ACTIVITY; SCHIZOPHRENIA; WRIST ACTIGRAPHY;

EID: 84926630507     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2015.00010     Document Type: Article

References (38)

1. Heckers S, Barch DM, Bustillo J, Gaebel W, Gur R, Malaspina D, et al. Structure of the psychotic disorders classification in DSM-5. Schizophr Res (2013) 150(1):11-4. doi: 10.1016/j.schres.2013.04.039
2. van Os J, Kapur S. Schizophrenia. Lancet (2009) 374(9690):635-45. doi:10.1016/S0140-6736(09)60995-8
3. Insel TR. Rethinking schizophrenia. Nature (2010) 468(7321):187-93. doi:10.1038/nature09552
4. Addington J, Addington D. Positive and negative symptoms of schizophrenia. Their course and relationship over time. Schizophr Res (1991) 5(1):51-9. doi:10.1016/0920-9964(91)90039-T
5. Arndt S, Andreasen NC, Flaum M, Miller D, Nopoulos P. A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change. Arch Gen Psychiatry (1995) 52(5):352-60. doi:10.1001/archpsyc.1995.03950170026004
6. Lang FU, Kosters M, Lang S, Becker T, Jager M. Psychopathological long-term outcome of schizophrenia - a review. Acta Psychiatr Scand (2013) 127(3):173-82. doi:10.1111/acps.12030
7. Savill M, Banks C, Khanom H, Priebe S. Do negative symptoms of schizophrenia change over time? A meta-analysis of longitudinal data. Psychol Med (2014):1-15. doi:10.1017/S0033291714002712
8. Morrens M, Docx L, Walther S. Beyond boundaries: in search of an integrative view on motor symptoms in schizophrenia. Front Psychiatry (2014) 5:145. doi:10.3389/fpsyt.2014.00145
9. Walther S, Strik W. Motor symptoms and schizophrenia. Neuropsychobiology (2012) 66(2):77-92. doi:10.1159/000339456
10. Brown S, Birtwistle J, Roe L, Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychol Med (1999) 29(3):697-701. doi:10.1017/S0033291798008186
11. Vancampfort D, Probst M, Sweers K, Maurissen K, Knapen J, De Hert M. Relationships between obesity, functional exercise capacity, physical activity participation and physical self-perception in people with schizophrenia. Acta Psychiatr Scand (2011) 123(6):423-30. doi:10.1111/j.1600-0447.2010.01666.x
12. Middelkoop HA, van Dam EM, Smilde-van den Doel DA, Van Dijk G. 45-hour continuous quintuple-site actimetry: relations between trunk and limb movements and effects of circadian sleep-wake rhythmicity. Psychophysiology (1997) 34(2):199-203. doi:10.1111/j.1469-8986.1997.tb02132.x
13. Walther S, Koschorke P, Horn H, Strik W. Objectively measured motor activity in schizophrenia challenges the validity of expert ratings. Psychiatry Res (2009) 169(3):187-90. doi:10.1016/j.psychres.2008.06.020
14. Walther S, Ramseyer F, Horn H, Strik W, Tschacher W. Less structured movement patterns predict severity of positive syndrome, excitement, and disorganization. Schizophr Bull (2014) 40(3):585-91. doi:10.1093/schbul/sbt038
15. Docx L, Sabbe B, Provinciael P, Merckx N, Morrens M. Quantitative psychomotor dysfunction in schizophrenia: a loss of drive, impaired movement execution or both? Neuropsychobiology (2013) 68(4):221-7. doi:10.1159/000355293
16. Walther S, Federspiel A, Horn H, Razavi N, Wiest R, Dierks T, et al. Resting state cerebral blood flow and objective motor activity reveal basal ganglia dysfunction in schizophrenia. Psychiatry Res (2011) 192(2):117-24. doi:10.1016/j.pscychresns.2010.12.002
17. Walther S, Federspiel A, Horn H, Razavi N, Wiest R, Dierks T, et al. Alterations of white matter integrity related to motor activity in schizophrenia. Neurobiol Dis (2011) 42(3):276-83. doi:10.1016/j.nbd.2011.01.017
18. Bracht T, Schnell S, Federspiel A, Razavi N, Horn H, Strik W, et al. Altered cortico-basal ganglia motor pathways reflect reduced volitional motor activity in schizophrenia. Schizophr Res (2013) 143(2-3):269-76. doi:10.1016/j.schres.2012.12.004
19. Wichniak A, Skowerska A, Chojnacka-Wojtowicz J, Taflinski T, Wierzbicka A, Jernajczyk W, et al. Actigraphic monitoring of activity and rest in schizophrenic patients treated with olanzapine or risperidone. J Psychiatr Res (2011) 45(10):1381-6. doi:10.1016/j.jpsychires.2011.05.009
20. Berle JO, Hauge ER, Oedegaard KJ, Holsten F, Fasmer OB. Actigraphic registration of motor activity reveals a more structured behavioural pattern in schizophrenia than in major depression. BMC Res Notes (2010) 3:149. doi:10.1186/1756-0500-3-149
21. Peralta V, Campos MS, De Jalon EG, Cuesta MJ. Motor behavior abnormalities in drug-naive patients with schizophrenia spectrum disorders. Mov Disord (2010) 25(8):1068-76. doi:10.1002/mds.23050
22. Peralta V, Cuesta MJ. Motor features in psychotic disorders. I. Factor structure and clinical correlates. Schizophr Res (2001) 47(2-3):107-16. doi:10.1016/S0920-9964(00)00035-9
23. Hoff AL, Svetina C, Shields G, Stewart J, DeLisi LE. Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia. Schizophr Res (2005) 78(1):27-34. doi:10.1016/j.schres.2005.05.010
24. Docx L, Sabbe B, Fransen E, Bervoets C, Hulstijn W, Van den Bossche B, et al. Longitudinal evaluation of the psychomotor syndrome in schizophrenia. J Neuropsychiatry Clin Neurosci (Forthcoming). doi:10.1111/j.1600-0447.2012.01846.x
25. Bachmann S, Bottmer C, Schroder J. Neurological soft signs in first-episode schizophrenia: a follow-up study. Am J Psychiatry (2005) 162(12):2337-43. doi:10.1176/appi.ajp.162.12.2337
26. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry (1997) 154(4 Suppl):1-63. doi:10.1176/ajp.154.4.1
27. Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry (2005) 162(3):441-9. doi:10.1176/appi.ajp.162.3.441
28. Van den Oord EJCG, Rujescu D, Robles JR, Giegling I, Birrell C, Bukszar J, et al. Factor structure and external validity of the PANSS revisited. Schizophr Res (2006) 82(2-3):213-23. doi:10.1016/j.schres.2005.09.002
29. Bervoets C, Docx L, Sabbe B, Vermeylen S, Van Den Bossche MJ, Morsel A, et al. The nature of the relationship of psychomotor slowing with negative symptomatology in schizophrenia. Cogn Neuropsychiatry (2014) 19(1):36-46. doi:10.1080/13546805.2013.779578
30. Peralta V, Cuesta MJ. The effect of antipsychotic medication on neuromotor abnormalities in neuroleptic-naive nonaffective psychotic patients: a naturalistic study with haloperidol, risperidone, or olanzapine. Prim Care Companion J Clin Psychiatry (2010) 12(2). doi:10.4088/PCC.09m00799gry
31. Peralta V, Cuesta MJ, Martinez-Larrea A, Serrano JF. Patterns of symptoms in neuroleptic-naive patients with schizophrenia and related psychotic disorders before and after treatment. Psychiatry Res (2001) 105(1-2):97-105. doi:10.1016/S0165-1781(01)00319-5
32. Ucok A, Ergul C. Persistent negative symptoms after first episode schizophrenia: a 2-year follow-up study. Schizophr Res (2014) 158(1-3):241-6. doi:10.1016/j.schres.2014.07.021
33. Foussias G, Remington G. Negative symptoms in schizophrenia: avolition and Occam's razor. Schizophr Bull (2010) 36(2):359-69. doi:10.1093/schbul/sbn094
34. Farrow TF, Hunter MD, Wilkinson ID, Green RD, Spence SA. Structural brain correlates of unconstrained motor activity in people with schizophrenia. Br J Psychiatry (2005) 187:481-2. doi:10.1192/bjp.187.5.481
35. Sponheim SR, Jung RE, Seidman LJ, Mesholam-Gately RI, Manoach DS, O'Leary DS, et al. Cognitive deficits in recent-onset and chronic schizophrenia. J Psychiatr Res (2010) 44(7):421-8. doi:10.1016/j.jpsychires.2009.09.010
36. Walther S, Horn H, Razavi N, Koschorke P, Wopfner A, Muller TJ, et al. Higher motor activity in schizophrenia patients treated with olanzapine versus risperidone. J Clin Psychopharmacol (2010) 30(2):181-4. doi:10.1097/JCP.0b013e3181d2ef6f
37. Andreasen NC. The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry Suppl (1989) (7):49-58.
38. Forbes C, Blanchard JJ, Bennett M, Horan WP, Kring A, Gur R. Initial development and preliminary validation of a new negative symptom measure: the clinical assessment interview for negative symptoms (CAINS). Schizophr Res (2010) 124(1-3):36-42. doi:10.1016/j.schres.2010.08.039